Trial intelligence / Profile preview

Effect of artificial tears on corneal curvature and visual quality before refractive surgery

ChiCTR2100044501Phase 4Recruiting

Sponsor
Department of Ophthalmology, The Second Affiliated Hospital of Anhui Medical University
Start
Apr 2021
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, open-label trial of sodium hyaluronate in xerophthalmia and dry eye syndrome (DED) (4 arms), sponsored by Department of Ophthalmology, The Second Affiliated Hospital of Anhui Medical University. Primary endpoint: Corneal curvature. Started Apr 2021; status: recruiting.

02

Drugs

sodium hyaluronate
03

Conditions

xerophthalmiadry eye syndrome (DED)

Beyond the preview

Go deeper on ChiCTR2100044501.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100044501.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call